Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

610.64
-14.9600-2.39%
Post-market: 610.640.00000.00%19:58 EDT
Volume:1.05M
Turnover:643.61M
Market Cap:66.76B
PE:15.93
High:628.00
Open:626.25
Low:607.88
Close:625.60
Loading ...
Feb 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities